This is the authors' abstract. We don't add key points for this paper.
The development of covalent inhibitors has revolutionized drug discovery, especially in targeting proteins involved in diseases like cancer, autoimmune disorders, and infectious diseases.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Faridoon et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: